The Director of Business Development for Clinical Assessment will hold a pivotal position in evaluating, assessing, and making decisions regarding novel clinical and pre-clinical prospects within our expanding oncology portfolio. Collaborating closely with internal stakeholders, this individual will serve as an integral member of the due diligence and licensing team, spearheading the evaluation of assets, in-licensing prospects, and other business intelligence and development opportunities.

Responsibilities

• Actively engage in the scientific, clinical, and commercial evaluation of oncology technologies across biotech start-ups, innovation hubs, and pharmaceutical companies.
• Take the lead in cross-functional asset assessment to support thorough due diligence processes.
• Participate in industry scientific gatherings, partnering events, and licensing forums to uphold the company's objectives and values.
• Develop and nurture strong relationships with key opinion leaders in pre-clinical and clinical oncology.
• Cultivate and maintain access to early cutting-edge science in oncology.
• Ensure all activities adhere to company standards.

Qualifications

• Must be inside UK/Europe
• Minimum 5 years in clinical development, specifically in oncology
• Over 3 years of expertise in oncology business development
• Willingness to travel (approx. 20%)
• German speaking